Company page

Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc. is a public company traded under the ticker OTLK in the American market. The company has a market capitalization of approximately $262.7 million. Outlook Therapeutics focuses on developing innovative therapies to address unmet medical needs.

OTLK:NASDAQUpdated August 28, 2026
Outlook Therapeutics, Inc. logo
Ticker
OTLK:NASDAQ
Asset type
Stock
Market cap
$157.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD